{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:39:32Z","timestamp":1785487172404,"version":"3.56.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01EO1504"],"award-info":[{"award-number":["01EO1504"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","onlinecjc.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.cjca.2017.07.010","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T02:45:12Z","timestamp":1500605112000},"page":"1217-1220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Between Disease-Causing and an Innocent Bystander: The Role of Titin as a Modifier in Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1363-8826","authenticated-orcid":false,"given":"Brenda","family":"Gerull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2017.07.010_bib1","doi-asserted-by":"crossref","first-page":"270ra276","DOI":"10.1126\/scitranslmed.3010134","article-title":"Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease","volume":"7","author":"Roberts","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cjca.2017.07.010_bib2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cjca.2015.08.016","article-title":"The rapidly evolving role of titin in cardiac physiology and cardiomyopathy","volume":"31","author":"Gerull","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2017.07.010_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng815","article-title":"Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy","volume":"30","author":"Gerull","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.cjca.2017.07.010_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.07.010_bib5","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/eurheartj\/ehv253","article-title":"Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy","volume":"36","author":"Akinrinade","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2017.07.010_bib6","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/eurheartj\/ehu050","article-title":"Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy","volume":"35","author":"van Spaendonck-Zwarts","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2017.07.010_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.07.010_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/CIRCGENETICS.112.962928","article-title":"Population-based variation in cardiomyopathy genes","volume":"5","author":"Golbus","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2017.07.010_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/cge.12741","article-title":"Relevance of truncating titin mutations in dilated cardiomyopathy","volume":"90","author":"Akinrinade","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.cjca.2017.07.010_bib10","doi-asserted-by":"crossref","first-page":"e0145284","DOI":"10.1371\/journal.pone.0145284","article-title":"Prevalence of titin truncating variants in general population","volume":"10","author":"Akinrinade","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2017.07.010_bib11","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/j.jacc.2016.08.079","article-title":"Clinical and mechanistic insights into the genetics of cardiomyopathy","volume":"68","author":"Burke","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.07.010_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ng.3719","article-title":"Titin-truncating variants affect heart function in disease cohorts and the general population","volume":"49","author":"Schafer","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.cjca.2017.07.010_bib13","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.cjca.2017.05.020","article-title":"Titin-truncating variants increase the risk of cardiovascular death in patients with hypertrophic cardiomyopathy","volume":"33","author":"Zhang","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2017.07.010_bib14","doi-asserted-by":"crossref","first-page":"e09406","DOI":"10.7554\/eLife.09406","article-title":"An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of titin in zebrafish","volume":"4","author":"Zou","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.cjca.2017.07.010_bib15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ejhg.2013.16","article-title":"Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy","volume":"21","author":"Roncarati","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cjca.2017.07.010_bib16","doi-asserted-by":"crossref","first-page":"e002645","DOI":"10.1161\/JAHA.115.002645","article-title":"Role of titin missense variants in dilated cardiomyopathy","volume":"4","author":"Begay","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2017.07.010_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jmedgenet-2012-101270","article-title":"Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing","volume":"50","author":"Lopes","year":"2013","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cjca.2017.07.010_bib18","author":"Walsh"},{"key":"10.1016\/j.cjca.2017.07.010_bib19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet Med"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X17303744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X17303744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T15:21:20Z","timestamp":1656775280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X17303744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0828282X17303744"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2017.07.010","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Between Disease-Causing and an Innocent Bystander: The Role of Titin as a Modifier in Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2017.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}